Literature DB >> 2412225

Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon.

H M Johnson, B A Torres.   

Abstract

Interferon primes macrophages for tumor cell killing by rendering them sensitive to triggering agents such as lipopolysaccharide. In an attempt to determine the nature of the priming signal, we tested phorbol 12-myristate 13-acetate, diacylglycerol, platelet-activating factor, arachidonic acid, leukotriene B4, and the calcium ionophore A23187 for their ability to prime mouse bone marrow-derived macrophages for activation to kill P815 mastocytoma target cells. The ionophore A23187 was the only substance that was able to replace the interferon priming signal. A23187 priming appeared to be due in part to induction of interferon alpha/beta in the macrophage cultures, since its effect was partially but specifically blocked by antibody to interferon alpha/beta. Consistent with this was the observation that A23187 induced interferon alpha/beta production in macrophage cultures. The fact that A23187 priming was not completely reversed by antibody to interferon would suggest that factors unrelated to interferon induction also played a role in macrophage priming. The failure of phorbol myristate acetate or diacylglycerol to prime macrophages for tumor cell killing would suggest that activation of protein kinase C is not sufficient for priming. Thus, A23187 appears to provide the priming signal for macrophage killing through the combination of interferon- and non-interferon-induced mechanisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412225      PMCID: PMC390673          DOI: 10.1073/pnas.82.17.5959

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Differences in mouse interferons according to cell source and mode of induction.

Authors:  N Maehara; M Ho; J A Armstrong
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

Review 2.  Turnover of inositol phospholipids and signal transduction.

Authors:  Y Nishizuka
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

3.  Biochemical models of gamma-interferon action: altered expression of transferrin receptors on murine peritoneal macrophages after treatment in vitro with PMA or A23187.

Authors:  J E Weiel; D O Adams; T A Hamilton
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

4.  Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP.

Authors:  S E Rittenhouse
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

5.  Ca2+ ionophores affect phosphoinositide metabolism differently than thyrotropin-releasing hormone in GH3 pituitary cells.

Authors:  R N Kolesnick; M C Gershengorn
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

6.  Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.

Authors:  T A Hamilton; D L Becton; S D Somers; P W Gray; D O Adams
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

7.  Activation of murine macrophage cell lines. Possible involvement of protein kinases in stimulation of superoxide production.

Authors:  C Kiyotaki; B R Bloom
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

8.  Release of Ca2+ from a non-mitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate.

Authors:  M Hirata; E Suematsu; T Hashimoto; T Hamachi; T Koga
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

9.  Leukotrienes: positive signals for regulation of gamma-interferon production.

Authors:  H M Johnson; B A Torres
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Interleukin 2-mediated events in gamma-interferon production are calcium dependent at more than one site.

Authors:  H M Johnson; T Vassallo; B A Torres
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

View more
  7 in total

1.  Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses.

Authors:  Nicole von Burg; Stéphane Chappaz; Anne Baerenwaldt; Edit Horvath; Somdeb Bose Dasgupta; Devika Ashok; Jean Pieters; Fabienne Tacchini-Cottier; Antonius Rolink; Hans Acha-Orbea; Daniela Finke
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

2.  Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-gamma or lipopolysaccharide.

Authors:  D J Maudsley; A G Morris
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

3.  Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages.

Authors:  Kewei Xu; Rene E Harrison
Journal:  J Biol Chem       Date:  2015-06-16       Impact factor: 5.157

4.  Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages.

Authors:  S J Huang; P N Monk; C P Downes; A D Whetton
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

6.  Platelet activating factor raises intracellular calcium ion concentration in macrophages.

Authors:  G W Conrad; T J Rink
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

7.  Ca2+/calmodulin-dependent kinase kinase alpha is expressed by monocytic cells and regulates the activation profile.

Authors:  Christopher B Guest; Eric L Deszo; Matthew E Hartman; Jason M York; Keith W Kelley; Gregory G Freund
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.